Covid-19 vaccines—immunity, variants, boosters
DH Barouch - New England Journal of Medicine, 2022 - Mass Medical Soc
Covid-19 Vaccines — Immunity, Variants, Boosters | New England Journal of Medicine Skip to
main content The New England Journal of Medicine homepage Advanced Search SEARCH …
main content The New England Journal of Medicine homepage Advanced Search SEARCH …
Update on the effectiveness of COVID-19 vaccines on different variants of SARS-CoV-2
N Firouzabadi, P Ghasemiyeh, F Moradishooli… - International …, 2023 - Elsevier
It has been more than three years since the first emergence of coronavirus disease 2019
(COVID-19) and millions of lives have been taken to date. Like most pandemics caused by …
(COVID-19) and millions of lives have been taken to date. Like most pandemics caused by …
T cell immunity to COVID-19 vaccines
EJ Wherry, DH Barouch - Science, 2022 - science.org
The development of multiple COVID-19 vaccines in record time is a major biomedical
achievement, but mechanistic immune correlates of vaccine protection remain to be …
achievement, but mechanistic immune correlates of vaccine protection remain to be …
Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: findings from a rapid living systematic evidence synthesis …
Background Synthesising evidence on the long-term vaccine effectiveness of COVID-19
vaccines (BNT162b2 [Pfizer–BioNTech], mRNA-1273 [Moderna], ChAdOx1 nCoV-19 …
vaccines (BNT162b2 [Pfizer–BioNTech], mRNA-1273 [Moderna], ChAdOx1 nCoV-19 …
[HTML][HTML] Bivalent Covid-19 vaccines—a cautionary tale
PA Offit - New England Journal of Medicine, 2023 - Mass Medical Soc
Bivalent Covid-19 Vaccines — A Cautionary Tale | New England Journal of Medicine Skip to
main content The New England Journal of Medicine homepage Advanced Search SEARCH …
main content The New England Journal of Medicine homepage Advanced Search SEARCH …
The immune response to SARS-CoV-2 in people with HIV
This review examines the intersection of the HIV and SARS-CoV-2 pandemics. People with
HIV (PWH) are a heterogeneous group that differ in their degree of immune suppression …
HIV (PWH) are a heterogeneous group that differ in their degree of immune suppression …
Efficacy, safety, and immunogenicity of a booster regimen of Ad26. COV2. S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo …
K Hardt, A Vandebosch, J Sadoff, M Le Gars… - The Lancet Infectious …, 2022 - thelancet.com
Background Despite the availability of effective vaccines against COVID-19, booster
vaccinations are needed to maintain vaccine-induced protection against variant strains and …
vaccinations are needed to maintain vaccine-induced protection against variant strains and …
Defending against SARS-CoV-2: The T cell perspective
P Almendro-Vázquez, R Laguna-Goya… - Frontiers in …, 2023 - frontiersin.org
SARS-CoV-2-specific T cell response has been proven essential for viral clearance, COVID-
19 outcome and long-term memory. Impaired early T cell-driven immunity leads to a severe …
19 outcome and long-term memory. Impaired early T cell-driven immunity leads to a severe …
Broad-spectrum pan-genus and pan-family virus vaccines
Although the development and clinical application of SARS-CoV-2 vaccines during the
COVID-19 pandemic demonstrated unprecedented vaccine success in a short time frame, it …
COVID-19 pandemic demonstrated unprecedented vaccine success in a short time frame, it …
Vaccine effectiveness against long COVID in children
OBJECTIVES Vaccination reduces the risk of acute coronavirus disease 2019 (COVID-19) in
children, but it is less clear whether it protects against long COVID. We estimated vaccine …
children, but it is less clear whether it protects against long COVID. We estimated vaccine …